Huai‐Qiang Ju

11.8k total citations · 6 hit papers
95 papers, 7.1k citations indexed

About

Huai‐Qiang Ju is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Huai‐Qiang Ju has authored 95 papers receiving a total of 7.1k indexed citations (citations by other indexed papers that have themselves been cited), including 58 papers in Molecular Biology, 47 papers in Cancer Research and 21 papers in Oncology. Recurrent topics in Huai‐Qiang Ju's work include Cancer-related molecular mechanisms research (25 papers), RNA modifications and cancer (23 papers) and Circular RNAs in diseases (13 papers). Huai‐Qiang Ju is often cited by papers focused on Cancer-related molecular mechanisms research (25 papers), RNA modifications and cancer (23 papers) and Circular RNAs in diseases (13 papers). Huai‐Qiang Ju collaborates with scholars based in China, United States and Hong Kong. Huai‐Qiang Ju's co-authors include Rui‐Hua Xu, De‐Shen Wang, Jin‐Fei Lin, Zhao-Lei Zeng, Dan Xie, Zerong Cai, Ting Li, Jia Liu, Zexian Liu and Peng Huang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Huai‐Qiang Ju

90 papers receiving 7.0k citations

Hit Papers

Circular RNA: metabolism, functions and interactions with... 2019 2026 2021 2023 2020 2019 2020 2019 2020 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Huai‐Qiang Ju China 41 5.3k 4.1k 1.0k 840 620 95 7.1k
Wenxin Qin China 44 5.3k 1.0× 3.3k 0.8× 1.4k 1.3× 853 1.0× 837 1.4× 137 7.7k
Jinjun Li China 45 4.8k 0.9× 3.1k 0.8× 1.7k 1.7× 553 0.7× 520 0.8× 137 7.0k
Yongguang Tao China 43 6.1k 1.2× 4.0k 1.0× 1.3k 1.3× 2.1k 2.5× 860 1.4× 170 8.3k
Ping Wei China 39 4.4k 0.8× 2.8k 0.7× 1.2k 1.1× 583 0.7× 743 1.2× 111 5.9k
Hongchuan Jin China 53 7.6k 1.4× 4.8k 1.2× 1.4k 1.4× 929 1.1× 693 1.1× 197 10.1k
Jichun Zhou China 30 2.9k 0.5× 2.0k 0.5× 685 0.7× 781 0.9× 448 0.7× 79 4.5k
Jiajun Zhu United States 17 3.7k 0.7× 2.3k 0.6× 786 0.8× 1.9k 2.2× 483 0.8× 30 5.7k
Florian A. Karreth United States 25 4.7k 0.9× 2.9k 0.7× 879 0.9× 343 0.4× 372 0.6× 53 5.9k
Zhao-Lei Zeng China 39 3.5k 0.7× 2.6k 0.6× 1.1k 1.1× 611 0.7× 407 0.7× 90 4.9k
Qi Cao United States 35 6.1k 1.1× 3.3k 0.8× 915 0.9× 2.0k 2.3× 325 0.5× 104 7.9k

Countries citing papers authored by Huai‐Qiang Ju

Since Specialization
Citations

This map shows the geographic impact of Huai‐Qiang Ju's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Huai‐Qiang Ju with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Huai‐Qiang Ju more than expected).

Fields of papers citing papers by Huai‐Qiang Ju

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Huai‐Qiang Ju. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Huai‐Qiang Ju. The network helps show where Huai‐Qiang Ju may publish in the future.

Co-authorship network of co-authors of Huai‐Qiang Ju

This figure shows the co-authorship network connecting the top 25 collaborators of Huai‐Qiang Ju. A scholar is included among the top collaborators of Huai‐Qiang Ju based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Huai‐Qiang Ju. Huai‐Qiang Ju is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Wei, Haojie Chen, Xiao Zhang, et al.. (2025). Nuclear mitochondrial acetyl-CoA acetyltransferase 1 orchestrates natural killer cell-dependent antitumor immunity in colorectal cancer. Signal Transduction and Targeted Therapy. 10(1). 138–138. 1 indexed citations
2.
Zheng, Yongqiang, Kai Yu, Jin‐Fei Lin, et al.. (2025). Deep learning prioritizes cancer mutations that alter protein nucleocytoplasmic shuttling to drive tumorigenesis. Nature Communications. 16(1). 2511–2511. 1 indexed citations
3.
Cai, Zerong, Yongqiang Zheng, Yan Hu, et al.. (2025). Construction of exosome non-coding RNA feature for non-invasive, early detection of gastric cancer patients by machine learning: a multi-cohort study. Gut. 74(6). 884–893. 12 indexed citations
4.
Deng, Yuqing, et al.. (2024). Immunomodulatory molecules in colorectal cancer liver metastasis. Cancer Letters. 598. 217113–217113. 13 indexed citations
5.
Nussinov, Ruth, Thomas Weichhart, Zodwa Dlamini, et al.. (2024). Directions to overcome therapy resistance in cancer. Trends in Pharmacological Sciences. 45(6). 467–471. 7 indexed citations
6.
Tian, Tian, Yongqiang Zheng, Hai‐Yu Mo, et al.. (2023). The liver microenvironment orchestrates FGL1-mediated immune escape and progression of metastatic colorectal cancer. Nature Communications. 14(1). 6690–6690. 44 indexed citations
7.
Seo, Gayoung, Clinton Yu, Han Han, et al.. (2023). The Hippo pathway noncanonically drives autophagy and cell survival in response to energy stress. Molecular Cell. 83(17). 3155–3170.e8. 16 indexed citations
8.
Chen, Yan‐Xing, Zixian Wang, Ying Jin, et al.. (2023). An immunogenic and oncogenic feature-based classification for chemotherapy plus PD-1 blockade in advanced esophageal squamous cell carcinoma. Cancer Cell. 41(5). 919–932.e5. 22 indexed citations
9.
He, Xinyu, Fan Xiao, Lei Qu, et al.. (2023). LncRNA modulates Hippo-YAP signaling to reprogram iron metabolism. Nature Communications. 14(1). 2253–2253. 34 indexed citations
10.
Wu, Qi‐Nian, Xiao-Jing Luo, Jia Liu, et al.. (2021). MYC-Activated LncRNA MNX1-AS1 Promotes the Progression of Colorectal Cancer by Stabilizing YB1. Cancer Research. 81(10). 2636–2650. 59 indexed citations
11.
Cai, Zerong, et al.. (2020). Circular RNA: metabolism, functions and interactions with proteins. Molecular Cancer. 19(1). 172–172. 848 indexed citations breakdown →
12.
Hu, Peishan, Ting Li, Jin‐Fei Lin, et al.. (2020). VDR–SOX2 signaling promotes colorectal cancer stemness and malignancy in an acidic microenvironment. Signal Transduction and Targeted Therapy. 5(1). 183–183. 46 indexed citations
13.
Lin, Jin‐Fei, et al.. (2020). LncRNA‐mediated posttranslational modifications and reprogramming of energy metabolism in cancer. Cancer Communications. 41(2). 109–120. 476 indexed citations breakdown →
14.
Liu, Zekun, Qi Zhao, Zhixiang Zuo, et al.. (2020). Systematic Analysis of the Aberrances and Functional Implications of Ferroptosis in Cancer. iScience. 23(7). 101302–101302. 163 indexed citations
15.
Wang, Yun, Jia-Huan Lu, Qi-Nian Wu, et al.. (2019). LncRNA LINRIS stabilizes IGF2BP2 and promotes the aerobic glycolysis in colorectal cancer. Molecular Cancer. 18(1). 174–174. 374 indexed citations breakdown →
16.
Lu, Yun-Xin, Huai‐Qiang Ju, Zexian Liu, et al.. (2018). ME1 Regulates NADPH Homeostasis to Promote Gastric Cancer Growth and Metastasis. Cancer Research. 78(8). 1972–1985. 95 indexed citations
17.
Ju, Huai‐Qiang, Haoqiang Ying, Tian Tian, et al.. (2017). Mutant Kras- and p16-regulated NOX4 activation overcomes metabolic checkpoints in development of pancreatic ductal adenocarcinoma. Nature Communications. 8(1). 14437–14437. 78 indexed citations
18.
Bai, Long, Feng Wang, Chao Ren, et al.. (2016). Chemotherapy plus bevacizumab versus chemotherapy plus cetuximab as first-line treatment for patients with metastatic colorectal cancer. Medicine. 95(51). e4531–e4531. 13 indexed citations
19.
Zhuang, Zhuonan, Huai‐Qiang Ju, Mitzi Aguilar, et al.. (2015). IL1 Receptor Antagonist Inhibits Pancreatic Cancer Growth by Abrogating NF-κB Activation. Clinical Cancer Research. 22(6). 1432–1444. 95 indexed citations
20.
Ju, Huai‐Qiang, Takeshi Gocho, Mitzi Aguilar, et al.. (2014). Mechanisms of Overcoming Intrinsic Resistance to Gemcitabine in Pancreatic Ductal Adenocarcinoma through the Redox Modulation. Molecular Cancer Therapeutics. 14(3). 788–798. 119 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026